Prescription Antibiotic Therapies for Small Intestinal Bacterial Overgrowth
On this page
In short: rifaximinRifaximin An antibiotic that is barely absorbed into the bloodstream, so it acts mainly inside the gut. It is a common prescription treatment for SIBO. is the most studied antibiotic for SIBO. Across 32 studies it cleared the overgrowth in about 71% of people, with side effects in about 5%5. For methane overgrowth, rifaximin is usually combined with neomycin or metronidazole: in one study the rifaximin-neomycin combination cleared methane in 87% of people, compared with 28% on rifaximin alone9. Antibiotics do not fix the reason SIBO developed, so it often comes back, and many people need more than one course.
Antibiotics are the standard medical treatment for small intestinal bacterial overgrowth (SIBO), recommended in the 2020 US clinical guideline1. The goal is not to sterilize the gut but to bring the number of bacteria in the small intestine back down. The choice of drug depends on which gas the breath test shows. For a side-by-side overview of antibiotics, herbal antimicrobials and the elemental dietElemental diet A liquid diet of pre-digested nutrients (amino acids, simple sugars and easily absorbed fats). They are absorbed in the upper small intestine, which starves bacteria further down., see our comparison of SIBO treatments.
How rifaximin works
Rifaximin stops bacteria from making the RNA they need to build proteins and multiply. Less than 0.4% of a dose is absorbed into the bloodstream, so almost all of it stays in the gut3. In a 2000 study, stool concentrations the day after a 3-day course averaged nearly 8,000 micrograms per gram4.
Rifaximin barely dissolves in water but dissolves 70 to 120 times better in bile acids. In laboratory tests, adding bile acids improved its effect against E. coli by more than 70%. Because bile is concentrated in the small intestine, the researchers suggested rifaximin may work best there, where SIBO is located3.
Animal research suggests rifaximin does more than kill bacteria. In rats exposed to chronic stress, it shifted the bacteria in the lower small intestine towards Lactobacillus species and prevented gut inflammation, damage to the gut barrier and gut pain. Neomycin, given for comparison, did not have these effects15.
Hydrogen-dominant SIBO
For hydrogen-dominant SIBO, rifaximin alone is the usual first choice11. The evidence:
- A 2013 meta-analysis of 10 trials found that antibiotics normalized the breath test in 51% of people, compared with 10% on placebo. Rifaximin, the most studied drug, normalized it in about 50%6.
- A larger 2017 meta-analysis of 32 studies with 1,331 people found that rifaximin cleared SIBO in about 71%, with higher doses linked to higher success. Symptoms improved or resolved in about 68% of those who cleared. The authors rated the quality of the studies as generally poor5.
Adding a fiber: partially hydrolyzed guar gum
In a 2010 randomized trial of 77 people with SIBO, adding 5 g a day of partially hydrolyzed guar gum (PHGG), a gentle soluble fiber, to rifaximin 1,200 mg a day for 10 days raised the clearance rate from 62% to 85%7. The researchers chose PHGG because it affects gut movement; why it helps is not fully understood.
Methane-dominant overgrowth (IMO)
Methane is made by archaeaArchaea Single-celled microorganisms that are distinct from bacteria. Methane-producing archaea (methanogens) are responsible for intestinal methanogen overgrowth., mainly Methanobrevibacter smithii, not by bacteria. In a 2001 laboratory study of 16 M. smithii strains from human stool, all were highly resistant to penicillin, vancomycin, gentamicin, ciprofloxacin, clindamycin and several other antibiotics. Metronidazole was the exception and inhibited them8.
Rifaximin alone works poorly against methane, so it is usually combined with neomycin or metronidazole11. In a 2010 review of the records of 74 people with methane on their breath test9:
- Methane cleared in 87% of those who took rifaximin plus neomycin for 10 days, compared with 33% on neomycin alone and 28% on rifaximin alone.
- Symptoms improved in 85% on the combination, compared with 63% on neomycin and 56% on rifaximin.
- Of those whose methane did not clear with rifaximin alone, 66% then cleared with the combination.
A 2026 systematic review of 39 studies came to a similar conclusion: no antibiotic was best for everyone, rifaximin gave the best balance of symptom relief and tolerability, and rifaximin plus neomycin had the strongest evidence for methane10. Our guide to methane SIBO covers the condition in more detail.
Hydrogen sulfide overgrowth
There are no clinical trials of antibiotics for hydrogen sulfide overgrowth. SIBO practitioners typically combine rifaximin with bismuth (the active ingredient in Pepto-Bismol) or high-dose oregano oil11.
Doses used in studies
The table shows the regimens used in the studies above. Your doctor will choose the drug, dose and length of treatment for you.
| Regimen | Used for | Dose and length in studies | Result |
|---|---|---|---|
| Rifaximin | Hydrogen | 1,200 mg a day for 10 days7 | 62% cleared7 |
| Rifaximin + PHGG | Hydrogen | Rifaximin 1,200 mg + PHGG 5 g a day for 10 days7 | 85% cleared7 |
| Rifaximin + neomycin | Methane | Rifaximin 400 mg three times a day + neomycin 500 mg twice a day for 10 days9 | 87% cleared methane9 |
| Rifaximin (IBS-D label dose) | IBS with diarrhea | 550 mg three times a day for 14 days2 | The approved dose for IBS-D, often also used for SIBO |
Other antibiotics
When rifaximin cannot be used, doctors sometimes prescribe antibiotics that are absorbed into the bloodstream, such as doxycycline, amoxicillin-clavulanate (Augmentin) or trimethoprim-sulfamethoxazole (Bactrim). SIBO practitioners report lower success rates with these than with rifaximin11. Because they act throughout the body, they are also more likely to disturb the bacteria in the colon. Herbal antimicrobials and the elemental diet are other alternatives.
Side effects
Rifaximin is usually well tolerated. In the 2017 meta-analysis, about 5% of people had side effects5. The drug label lists headache in travelers’ diarrhea trials and nausea and raised liver enzymes in IBS trials. As with any antibiotic, it can rarely allow Clostridioides difficile to overgrow in the colon, so diarrhea that starts or worsens during or after treatment should be checked by a doctor2.
Neomycin is mostly not absorbed, but about 3% of a dose does reach the bloodstream. Its label carries a boxed warning: it can damage the kidneys and cause permanent hearing loss and balance problems, even at recommended doses. The risk rises with higher doses and longer treatment, so the label advises checking hearing and kidney function12.
Metronidazole often causes nausea and a sharp metallic taste. Its label warns against drinking alcohol during treatment and for at least three days afterwards, and it can rarely cause nerve damage (peripheral neuropathy), especially with longer use13.
After antibiotics: relapse and retesting
Antibiotics lower the bacterial load but do not fix the root causes that allowed the overgrowth, such as slow gut movement or low stomach acid. In a 2008 study of 80 people treated successfully with rifaximin, SIBO had returned in about 13% after 3 months, 28% after 6 months and 44% after 9 months14.
SIBO practitioners describe a standard course as about 2 weeks, sometimes 3 when gas levels are very high (70 ppmParts per million (ppm) The unit breath-test laboratories use to report the concentration of hydrogen, methane and hydrogen sulfide in a breath sample. or more), followed by a repeat breath test. Most people need 2 to 5 courses of antibiotics or herbs, and stretching one course much longer rarely helps11. To reduce the chance of relapse, treatment is usually followed by a prokinetic and a prevention plan. In persistent cases, some practitioners add biofilm disruptors.
Common questions
Is rifaximin approved for SIBO?
No. In the US, rifaximin (Xifaxan) is approved for travelers’ diarrhea, hepatic encephalopathy and IBS with diarrhea2. Its use for SIBO is “off-label”, although it is the antibiotic the US guideline and most studies focus on15.
What if the first course does not work?
Treatment is usually adjusted using the repeat breath test. If methane is still present after rifaximin alone, adding neomycin cleared it in 66% of people in one study9. Other options include another round, a different antibiotic, herbal antimicrobials or an elemental diet11.
Will SIBO come back after antibiotics?
Often, yes. Up to 44% of people relapse within 9 months14, which is why addressing the underlying cause and using a prokineticProkinetic A medication or supplement that stimulates gut movement. Prokinetics are often used after SIBO treatment to support the migrating motor complex and reduce relapse. matter as much as the antibiotic itself.
Works Cited & Scientific References
15
▼
- ACG clinical guideline: small intestinal bacterial overgrowth - Am J Gastroenterol 2020 (PubMed)
- Xifaxan (rifaximin) prescribing information - DailyMed, US National Library of Medicine
- Bile acids improve the antimicrobial effect of rifaximin - Antimicrob Agents Chemother 2010 (PubMed)
- In vitro activity and fecal concentration of rifaximin after oral administration - Antimicrob Agents Chemother 2000 (PubMed)
- Systematic review with meta-analysis: rifaximin is effective and safe for the treatment of small intestine bacterial overgrowth - Aliment Pharmacol Ther 2017 (PMC)
- Meta-analysis: antibiotic therapy for small intestinal bacterial overgrowth - Aliment Pharmacol Ther 2013 (PubMed)
- Clinical trial: the combination of rifaximin with partially hydrolysed guar gum is more effective than rifaximin alone in eradicating small intestinal bacterial overgrowth - Aliment Pharmacol Ther 2010 (PubMed)
- Isolation and antimicrobial susceptibility testing of fecal strains of the archaeon Methanobrevibacter smithii - Chemotherapy 2001 (PubMed)
- A combination of rifaximin and neomycin is most effective in treating irritable bowel syndrome patients with methane on lactulose breath test - J Clin Gastroenterol 2010 (PubMed)
- Antibiotic therapy for small intestinal bacterial overgrowth: a systematic review of comparative efficacy, clinical-test discordance, and pediatric evidence gaps - Front Pharmacol 2026 (PMC)
- SIBO antibiotics - SIBOinfo
- Neomycin sulfate tablets prescribing information - DailyMed, US National Library of Medicine
- Metronidazole tablets prescribing information - DailyMed, US National Library of Medicine
- Small intestinal bacterial overgrowth recurrence after antibiotic therapy - Am J Gastroenterol 2008 (PubMed)
- Rifaximin alters intestinal bacteria and prevents stress-induced gut inflammation and visceral hyperalgesia in rats - Gastroenterology 2014 (PMC)
Topics & Tags: